![]() |
|||
|
|
|
|
| UPDATE: November 2008 | MW: 206.34 | MF: C8H14O2S2 |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
subcutaneous | rat
lowest published toxic dose: 480 mg/kg (30 day male)
|
Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands
|
NYKZAU 68,265,1972
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lethal dose (50 percent kill): 160 mg/kg
|
N/R
|
NIIRDN 6,454,1982
|
intraperitoneal | mouse
lowest published toxic dose: 25 mg/kg
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TOPADD 32,527,2004
|
intraperitoneal | rat
lethal dose (50 percent kill): 200 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Respiratory depression
NYKZAU 68,265,1972
|
intravenous | mouse
lethal dose (50 percent kill): 197 mg/kg
|
N/R
|
NYKZAU 60,278,1964
|
intravenous | rat
lethal dose (50 percent kill): 180 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Respiratory depression
NYKZAU 68,265,1972
|
intravenous | rat
lowest published toxic dose: 60 mg/kg
|
Lung, Thorax, or Respiration: Other changes | Biochemical: Metabolism (intermediary): Lipids including transport Biochemical: Metabolism (intermediary): Other proteins
JPHPH* 58,541,2007
|
oral | human
lowest published toxic dose: 0.83 mg/kg
|
Blood: Change in clotting factors
|
FATOAO 53,47,1990
|
oral | mouse
lethal dose (50 percent kill): 502 mg/kg
|
N/R
|
ARTODN 41,79,1978
|
oral | rat
lethal dose (50 percent kill): 1,130 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Respiratory depression
NYKZAU 68,265,1972
|
oral | rat
lowest published toxic dose: 100 mg/kg
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TXCYAC 243,261,2008
|
subcutaneous | mouse
lethal dose (50 percent kill): 200 mg/kg
|
N/R
|
NIIRDN 6,454,1982
|
subcutaneous | rat
lethal dose (50 percent kill): 230 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Respiratory depression
NYKZAU 68,265,1972
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | rat
lowest published toxic dose: 50 mg/kg/5 day- intermittent
|
Kidney, Ureter, and Bladder: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes Biochemical: Metabolism (intermediary): Other proteins
TXCYAC 177,187,2002
|
oral | human
lowest published toxic dose: 543.2 mg/kg/8 week- intermittent
|
Gastrointestinal: Nausea or vomiting | Gastrointestinal: Other changes
JDUCO* 18,79,2004
|
oral | human
lowest published toxic dose: 240.8 mg/kg/4 week- intermittent
|
Nutritional and Gross Metabolic: Conditioned vitamin deficiency
|
EJCPAS (),A52,1999
|
oral | rat
lowest published toxic dose: 1,000 mg/kg/10 day- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
JAPTO* 24,21,2004
|
oral | rat
: 250 mg/kg/10 day- intermittent
|
Cardiac: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Metabolism (intermediary): Lipids including transport
EJPHAZ 543,92,2006
|
oral | rat
lowest published toxic dose: 175 mg/kg/7 day- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TXCYAC 243,261,2008
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
CTOXAO 40,715,2002
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 5 mg/m3, JUN2003
|
| |||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X9998 |
Number of Industries 2; Total Number of Facilities 138; Number of Occupations 2; Total Number of Employees Exposed 429; Total Number of Female Employees Exposed 141 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
CTOXAO
|
Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW.
|
EJCPAS
|
European Journal of Clinical Pharmacology. (Springer-Verlag New York, Inc., Service Center,
44 Hartz Way, Secaucus, NJ 07094) V.3- 1970-
|
EJPHAZ
|
European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1967-
|
FATOAO
|
Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939-
|
JAPTO*
|
Journal of Applied Toxicology (John Wiley & Sons, Ltd., Oldlands Way Bognor Regis West Sussex,
PO22 9SA England) V.1- 1981-
|
JDUCO*
|
Journal of Diabetes and Its Complications (Elsevier) V.6- 1992-
|
JPHPH*
|
|
NIIRDN
|
Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan)
|
NYKZAU
|
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto
Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40-
1944-
|
TOPADD
|
Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical
Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
| |